CA Dawn To Offload 10.2% Stake In Indegene Ltd Worth Rs.1,420 Crore

    Synopsis:

    CA Dawn Investments, a Carlyle affiliate, will offload 10.2% in Indegene Ltd through a Rs.1,420 crore block deal. The 2.44 crore shares will be sold at Rs.580 each, reflecting a 6.4% discount to the Indegene Ltd share price.


    CA Dawn Investments, an affiliate of US-based private equity major Carlyle Group, is expected to sell a 10.2% stake in healthcare technology company Indegene Ltd via block deals valued at around Rs.1,420 crore. The proposed transaction includes the sale of 2.44 crore equity shares at a floor price of Rs.580 per share, which represents a 6.4% discount to the prevailing Indegene Ltd share price.

    Also read: Jayanti Sinha To Offload 1.42% Stake In Alkem Laboratories Via Block Deal

    Indegene Limited

    Trade

    511.42.10 (0.41 %)

    Updated - 13 July 2026
    512.35day high
    DAY HIGH
    502.20day low
    DAY LOW
    413620
    VOLUME (BSE)

    Key Takeaways

    • Seller: CA Dawn Investments (Carlyle Group affiliate)

    • Company: Indegene Ltd

    • Stake Sale: 10.2%

    • Deal Value: Rs.1,420 crore

    • Number of Shares: 2.44 crore

    • Floor Price: Rs.580

    • Discount to Market Price: 6.4%

    • Brokers: Kotak, IIFL

    Also read: Flipkart To Sell 6% Stake In Aditya Birla Fashion For Rs.600 Crore

    Block Deal Details And Market Impact

    Particulars

    Details

    Total Shares Offered

    2.44 crore

    Floor Price Per Share

    Rs.580

    Market Price (Approx.)

    Rs.620

    Discount to Market Price

    6.4%

    Total Deal Value

    Rs.1,420 crore

    Brokers Handling Transaction

    Kotak, IIFL

    The deal comes shortly after Indegene Ltd’s stock market debut on 13 May 2024, where the stock listed at Rs.655 on NSE and Rs.659.70 on BSE—marking a strong listing premium of nearly 46% over the issue price of Rs.452. Since then, Indegene Ltd share price has seen moderate volatility but remains above the IPO price.

    Company Background And Listing History

    Established in 1998, Indegene Ltd provides technology-driven healthcare solutions to pharmaceutical, biotech, and medical device companies. It assists businesses across product development, market launch, and sales acceleration.

    The company had a robust listing in May 2024, reflecting strong investor interest. As of the most recent session, Indegene Ltd share price closed at Rs.617.20 on BSE, up by Rs.12.25 or 2.02%. The planned stake sale could introduce temporary price movement due to supply-side pressure, though the company’s long-term outlook remains supported by its global clientele and digital-first model.

    Also read: TPG To Sell 2.1% Stake In Tata Technologies For Rs.634 Crore

    Source: CNBCTV18

    Share this article: 

    Published Date : 04 Jun 2025

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |